Equity · Consumer defensive
The Clorox Company (CLX) perpetual futures
CLX perpetual futures on 1 crypto exchange – live perp price vs the stock, funding rate, open interest and where to trade CLXUSDT.
The Clorox Company manufactures and markets consumer and professional products, including cleaning, household, lifestyle and international brands such as Clorox, Glad, Brita and Burt's Bees.
Price chart
Interactive TradingView chart
TradingView symbol NYSE:CLX
Loads TradingView's third-party widget (about 1 MB) on demand.
Trading data
Perpetual market activity
1/1 live markets
Trading data
Perpetual market activity
Spot performance
MEXCTradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kThin liquidity · 1 of 1 venues absorb $10k · Typical cost: +21.4 bps
Cheapest execution: MEXC · +21.4 bps
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
CLXTightest spread
CLXHighest volume
CLXFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketNext catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
Latest annualAnalysts
Price targets in USD| Consensus rating | Hold |
|---|---|
| Average 12-month price target | $88.88 |
| 12-month target range (low – high) | $74 – $99 |
| Ratings in the provider's consensus | 29 |
Price targets as of 2026-11-12
Analyst rating history
Ratings| Month | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| Nov 2026 | 1 | 1 | 14 | 2 | 2 |
| Oct 2026 | 0 | 1 | 14 | 2 | 2 |
| Sep 2026 | 0 | 1 | 14 | 2 | 2 |
| Aug 2026 | 0 | 1 | 14 | 2 | 2 |
| Jul 2026 | 0 | 2 | 14 | 2 | 2 |
| Jun 2026 | 0 | 2 | 13 | 2 | 2 |
| May 2026 | 0 | 2 | 13 | 2 | 2 |
| Apr 2026 | 0 | 2 | 14 | 2 | 2 |
| Mar 2026 | 1 | 2 | 14 | 2 | 1 |
| Feb 2026 | 1 | 2 | 14 | 2 | 2 |
| Jan 2026 | 0 | 2 | 13 | 2 | 2 |
| Dec 2025 | 0 | 2 | 13 | 2 | 2 |
Ownership
Institutional · 2026-Q3Reference market activity
CLX-PERPPrice performance
11Insider activity
FY2026 Q4Insider transactions
25Director Pierre R. Breber bought 4,000 common shares of Clorox on the open market at $100.0627 each on Nov 4, 2026, leaving 22,000 shares owned.
Clorox CEO Linda J. Rendle received a grant of 29,352 common shares at $80.41 and had 12,681 shares withheld for taxes at the same price, leaving 269,807 shares owned.
Clorox officer Laurene E. Peck received an award of 1,172 common shares at $80.41 and had 369 shares withheld for taxes, leaving 10,017 shares owned.
Clorox officer Kirsten Marriner was granted 6,637 common shares and had 4,093 shares withheld for taxes, both at $80.41; she held 79,498 shares afterward.
Clorox officer Hyder Chris T received 4,191 common shares as an award at $80.41 and had 1,632 shares withheld for taxes at the same price on 2026-10-05, leaving 92,986 shares owned.
Clorox officer Hilt Angela C received a 6,637-share Common Stock award at $80.41 and had 4,647 shares withheld for taxes at the same price, leaving 69,767 shares owned after the Oct 5, 2026 transactions.
Clorox CFO Luc Bellet received a 1,677-share Common Stock award at $80.41 and had 1,611 shares withheld for taxes at the same price on 2026-10-05, leaving 74,860 shares owned.
Clorox officer Nina Barton reported disposing of 1,106 common shares at $80.41 via an F-Tax code transaction (tax withholding), leaving 36,179 shares owned. No open-market purchase or sale was reported.
Clorox director Christopher J. Williams received two grants of Deferred Stock Units totaling 616 shares, at $0.00, raising his holdings to 23,275 units.
Director Russell J. Weiner received two grants totaling 643 deferred stock units at $0.00 on Aug 28 and Sep 30, 2026. Awards are compensation; he owned 19,243 units after the latest grant.
Clorox director Matthew J. Shattock received a grant of 648 deferred stock units (A-Award, $0.00) on 2026-09-30, bringing his holdings to 21,851 units.
Filings
PendingTranscripts
Earnings callsFY2027 Q12026-11-02
Earnings calls
AI summary
mixedClorox reported better-than-expected first quarter FY27 results, with CEO Linda Rendle citing strong execution, favorable timing and steady progress in organic sales and market share. The company now expects fiscal year input cost inflation of about $240 million, roughly $40 million above its initial expectation, driven by resin and a broad range of commodities plus transportation and supplier costs, assuming Brent averages around $100. Full-year organic sales growth is guided to 3.5% to 4.5%, including about 3.5 points from lapping the ERP transition, implying flat to up 1% excluding ERP. Mitigation leans primarily on productivity and cost savings, supplemented by targeted pricing already taken across all four reporting segments and potential additional pricing in the back half. GOJO integration is progressing, with line of sight to the full $50 million synergy target and first-year adjusted EPS accretion now expected positive rather than neutral. The Board has appointed Fabian Garcia as next CEO, effective January; Rendle remains focused on execution through the transition.
Key takeaways
- Organic sales trajectory improving sequentially; company expects flat to up 1% organic growth excluding the ERP lap benefit for the full year
- Input cost inflation outlook raised to about $240 million, roughly 2.5x the historical annual average rate, with inflation more pronounced in the first half
- Margin recovery driven majority by productivity and cost savings, with targeted pricing and RGM contributing; first quarter cost savings were among the highest on record
- Targeted pricing already implemented across all four reporting segments, including a high-single-digit increase on Glad Trash in July; additional pricing possible in the back half
- Fabian Garcia named next CEO; Linda Rendle remains focused on delivering plans until January
Financial highlights
- Full-year organic sales growth guided to 3.5% to 4.5%, including about 3.5 points of benefit from lapping the ERP transition
- Full-year input cost inflation now expected at about $240 million, about $40 million above the beginning-of-year expectation
- First quarter cost savings were one of the highest quarterly levels on record
- GOJO acquisition first-year adjusted EPS impact revised to positive from an initial estimate of about neutral
Guidance
- Organic sales growth excluding ERP impact expected flat to plus 1% for the full year, down slightly in the front half and up slightly in the back half
- Second quarter organic sales expected flat to down 2%, reflecting shipment comparison and merchandising timing dynamics
- Gross margin expected to compress on average for the full year, with front half about 1 to 1.5 points below the average and the back half higher; company expects to exit the year with much stronger gross margin
- SG&A outlook adjusted from 16% to 15%, partly reflecting accelerated GOJO synergies, with rounding noted
Q&A themes
- Commodity cost inflation assumptions and phasing, including resin, transportation and a Brent assumption of around $100
- Mitigation mix of cost savings, RGM and targeted pricing, and confidence in back-half margin recovery
- Market share performance by category, including gains in Home Care, Brita, Hidden Valley and Kingsford, with Litter still a drag
- GOJO integration progress and line of sight to the full $50 million synergy target
Risks
- Input cost environment remains volatile and uncertain, with inflation broader than energy alone and potentially exceeding current assumptions
- Consumer value-seeking behavior and elevated competitive activity could pressure volumes and share, particularly in Litter
- Pricing actions take time to flow through margins, and additional pricing may be needed if commodity pressure persists
FY2026 Q42026-08-03
Earnings calls
AI summary
mixedCEO Linda Rendle said FY2026 ran in a dynamic environment of value-seeking consumers, heightened competition and inflation, and that most businesses met or exceeded expectations while actions were taken where they fell short. For FY2027, Clorox expects category growth consistent with FY2026, continued market share progress after sequential improvement in FY2026 (aggregate share down one-tenth of a point, June exit rate nearly flat), and a slower Q1 driven mainly by Kingsford grilling timing and merchandising. CFO Luc Bellet guided FY2027 inflation above $200 million (more than double the historical $75-100 million range), weighted to the first half, assuming Brent crude around $90 per barrel, with productivity the primary offset and strategic pricing secondary; gross margin should begin recovering in the back half. GOJO/Purell is performing ahead of plan, was accretive rather than dilutive in Q4, and is expected to be accretive to adjusted EPS next fiscal year. Rendle also addressed her planned CEO transition, saying she is cancer-free and the Board's search is progressing as expected.
Key takeaways
- Most businesses performed at or above expectations in FY2026; decisive actions were taken where performance lagged, and management cited sequential improvement in consumption and share (aggregate share down 0.1 point, June exit rate nearly flat)
- Q1 FY2027 is expected to be a timing-related 'blip,' mainly Kingsford grilling seasonality and merchandising choices, with trends expected closer to FY2026 levels, particularly in the back half
- Home Care posted 8 consecutive quarters of share growth; Glad and Hidden Valley Ranch showed share turnarounds, while Litter/Fresh Step remains early in its fix and Kingsford was hit by weather-disrupted grilling holidays
- GOJO integration is going as planned and in some places slightly ahead; the business beat its Q4 targets and is expected to grow mid-single digit, moving to mid- to high single digits as revenue synergies materialize
- The ERP implementation is complete and the company is in stabilization mode, with optimization and productivity benefits expected later this fiscal year and into next fiscal year
Financial highlights
- FY2027 inflation expected above $200 million, more than double the historical $75 million to $100 million range, with the impact more pronounced in the first half
- FY2027 outlook assumes average Brent crude oil of about $90 per barrel; inflation also spans supplier costs, ocean freight, trucking and other logistics
- GOJO adds roughly 0.5 point of gross margin dilution, less than 1 point of SG&A and about 1 point lower advertising as a percent of sales versus legacy Clorox
- Interest expense for FY2027 is about $210 million; free cash flow is expected in the 11% to 13% of sales targeted range
Guidance
- Organic sales outlook of flat to up slightly, with net pricing positive and volume negative per management's construct
- Gross margin guided at about 42%, with gross margin recovery expected to begin in the back half; full-year gross margin is not expected to be fully recovered
- EPS growth guidance range is wider than usual due to cost/commodity environment and timing; the main EPS impact is the lower gross margin
- Advertising and sales promotion at about 10% of sales including GOJO; excluding GOJO, spending is over 11% of sales, phased like prior years with heavier spending in Q3 and Q4
Q&A themes
- Category growth and market share trajectory, including Q1 timing versus full-year improvement
- Pricing strategy: targeted/strategic pricing including a Glad trash increase, versus limited broad pricing amid value-seeking consumers
- Inflation and gross margin bridge, with productivity as the primary offset and back-half margin recovery
- GOJO integration and financial impacts, plus Fresh Step/Litter turnaround and ERP-enabled productivity
Risks
- Inflation above $200 million, more than double the historical range, is concentrated in the first half and extends beyond energy into logistics and supplier costs
- Consumer value-seeking behavior and muted category growth, plus competitive activity, could pressure share, particularly in Litter and Kingsford
- Geopolitical volatility (Middle East, oil prices) and promotional/merchandising timing create uncertainty in the outlook
Company news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.Company data
Company intelligence
Updated: Nov 12, 2026, 05:15 PM UTC
Company data
Company intelligence
Company profile
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Chief executive
- Linda J. Rendle
- Employees
- 9,200
- IPO date
- Mar 21, 1983
- Country
- US
- Exchange
- New York Stock Exchange
Rating factors
- Return on equityi
- 1
- Return on assetsi
- 4
- Debt to equityi
- 1
- Price to earningsi
- 3
- Price to booki
- 1
Company press releases
Congressional disclosures
Senate
House
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| VTI | 0.01% | 3.9M |
| VOO | 0.01% | 3.2M |
| MOAT | 2.66% | 3M |
| VB | 0.12% | 2.7M |
| RSP | 0.23% | 2.3M |
| NOBL | 1.75% | 2M |
| VBR | 0.22% | 1.8M |
| IVV.AX | 0.02% | 1.6M |
| ACSRX | 0.85% | 1.5M |
| SPY | 0.02% | 1.5M |
| VSCA.S | 0.04% | 1.3M |
| VCPA.S | 0.03% | 1.3M |
Analyst track record
How the analysts covering CLX have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 118 | 319 |
| Analysts | 15 | 19 |
| Buy / hold / sell | 3 / 84 / 31 | 17 / 213 / 89 |
| Upgrades / downgrades / initiations | 1 / 2 / 0 | 8 / 4 / 4 |
| Price targets hit / missed | 67 / 46 (59%) | 67 / 237 (22%) |
| Avg. return after a rating (TipRanks) | +6.4% | -13.0% |
| Best / worst call | +46.1% / -28.9% | +46.1% / -42.8% |
After buy calls on this stock: not enough measured cases yet
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Nov 4, 2026 | Dara MohsenianMorgan StanleyNov 4, 2026 | HoldMaintained | $94.00↗ | article ↗ |
| Nov 3, 2026 | Bonnie HerzogGoldman SachsNov 3, 2026 | SellMaintained | $74.00↗ | article ↗ |
| Nov 3, 2026 | Peter GromUBSNov 3, 2026 | HoldMaintained | $96.00↗ | article ↗ |
| Nov 3, 2026 | Andrea Faria TeixeiraJ.P. MorganNov 3, 2026 | SellReiterated | $86.00↗ | article ↗ |
| Nov 3, 2026 | Anna LizzulBank of America SecuritiesNov 3, 2026 | HoldMaintained | $96.00↗ | article ↗ |
TipRanks data · computed Nov 12, 2026 · 118 ratings
Frequently asked questions
Where can I trade CLX perpetual futures?
The Clorox Company (CLX) perpetual futures trade on one crypto venue: MEXC. PerpEquities shows its live price, funding rate, open interest and liquidity.
Can I trade CLX around the clock?
Yes. Unlike the underlying stock, CLX perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on CLX perpetuals?
Right now the CLX perp funding rate is -3.2% annualized (one venue). A positive rate means longs pay shorts. PerpEquities shows the live rate and its history.
How does the CLX perp price compare to the The Clorox Company stock?
The venue-median CLX perp mark is $107.9 versus a reference stock price of $107.9, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a CLX perpetual future?
A CLX perpetual is a derivative that tracks the price of The Clorox Company with no expiry date. It lets you take long or short exposure to The Clorox Company on crypto venues, around the clock.
What is CLXUSDT perpetual?
CLXUSDT is the symbol most crypto exchanges use for the The Clorox Company perpetual settled in USDT (Tether). It tracks the CLX share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/clx-perp"><img src="https://perpequities.com/badge/clx-perp.svg" width="240" height="64" alt="CLX perpetuals · perpequities.com" loading="lazy"></a>